...
首页> 外文期刊>Nature Communications >SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma
【24h】

SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma

机译:SOX2是皮肤鳞状细胞癌中癌症起始潜力的癌症特异性调节剂

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Although the principles that balance stem cell self-renewal and differentiation in normal tissue homeostasis are beginning to emerge, it is still unclear whether cancer cells with tumour initiating potential are similarly governed, or whether they have acquired distinct mechanisms to sustain self-renewal and long-term tumour growth. Here we show that the transcription factor Sox2 , which is not expressed in normal skin epithelium and is dispensable for epidermal homeostasis, marks tumour initiating cells (TICs) in cutaneous squamous cell carcinomas (SCCs). We demonstrate that Sox2 is required for SCC growth in mouse and human, where it enhances Nrp1 / Vegf signalling to promote the expansion of TICs along the tumour–stroma interface. Our findings suggest that distinct transcriptional programmes govern self-renewal and long-term growth of TICs and normal skin epithelial stem and progenitor cells. These programmes present promising diagnostic markers and targets for cancer-specific therapies.
机译:尽管平衡干细胞自我更新和正常组织稳态中分化的原理已开始出现,但仍不清楚是否具有类似肿瘤起始潜能的癌细胞是否受到类似的控制,或者它们是否已获得维持自我更新和长期维持的独特机制。期肿瘤生长。在这里,我们显示转录因子Sox2在皮肤鳞状细胞癌(SCCs)中标记为肿瘤起始细胞(TICs),该转录因子在正常皮肤上皮细胞中不表达,对于表皮稳态是必不可少的。我们证明,Sox2是小鼠和人类SCC生长所必需的,它增强了Nrp1 / Vegf信号,从而促进TICs沿着肿瘤-基质界面扩展。我们的发现表明,不同的转录程序控制TIC和正常皮肤上皮干细胞和祖细胞的自我更新和长期生长。这些程序为癌症特异性疗法提供了有前途的诊断标记和靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号